Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene transfer and kidney disease

E Imai1, Y Isaka, Y Akagi

  • 1Osaka University School of Medicine, Japan.

Journal of Nephrology
|April 30, 1998
PubMed
Summary

Gene therapy using chimeric proteins can suppress experimental glomerulonephritis by inhibiting transforming growth factor-beta (TGF-β) overexpression. This approach shows potential for treating kidney diseases characterized by glomerulosclerosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Plasma CD147 reflects histological features in patients with lupus nephritis.

Lupus·2014
Same author

Longitudinal distortions and transversal fluctuations of an actin filament sliding on Myosin molecules.

Journal of biological physics·2013
Same author

Effects of olmesartan on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy: a multicentre, randomised, placebo-controlled study.

Diabetologia·2011
Same author

FGF-2 stimulates periodontal regeneration: results of a multi-center randomized clinical trial.

Journal of dental research·2010
Same author

Clinicopathological study of expression of lymphatic vessels in renal allograft biopsy after treatment for acute rejection.

Transplantation proceedings·2009
Same author

A clinicopathologic study of p27(kip1) expression in renal allograft biopsy.

Transplantation proceedings·2007

Area of Science:

  • Molecular biology
  • Nephrology
  • Gene therapy

Background:

  • Transforming growth factor-beta (TGF-β) overexpression in glomeruli causes glomerulosclerosis.
  • Gene transfer techniques like the HVJ-liposome method are advancing renal disease research.
  • Antisense oligonucleotides can inhibit TGF-β action and suppress experimental glomerulonephritis.

Purpose of the Study:

  • To investigate the efficacy of in vivo gene transfer of chimeric proteins in suppressing experimental glomerulonephritis.
  • To determine if chimeric proteins targeting TGF-β signaling can reduce extracellular matrix expansion in glomeruli.

Main Methods:

  • Gene transfer of TGF-beta cDNA to induce overexpression and glomerulosclerosis in rats.
  • Administration of antisense oligonucleotides to inhibit TGF-β.

Related Experiment Videos

  • In vivo gene transfer of chimeric proteins (extracellular domain of TGF-β type II receptor fused with IgC-Fc).

    • Main Results:

    • Overexpression of TGF-β via gene transfer led to glomerulosclerosis.
    • Inhibition of TGF-β action suppressed experimental glomerulonephritis development.
    • Gene transfer of chimeric proteins suppressed glomerular TGF-β expression and extracellular matrix expansion.

    Conclusions:

    • Dysregulation of TGF-β is crucial in the development of glomerulosclerosis.
    • Targeting TGF-β overexpression through gene transfer offers a potential therapeutic strategy for slowing kidney disease progression.
    • Molecular biological intervention holds promise for treating renal diseases.